September 15, 2014

Posts tagged as: cholesterol back to homepage

1162 Lawsuits Filed Against Pfizer for Damages due to Lipitor 1162 Lawsuits Filed Against Pfizer for Damages due to Lipitor

Lawsuits filed against Pfizer for their blockbuster cholesterol-lowering drug Lipitor reached 1162 cases filed in August. Almost all of theses cases have been filed since April, when a new study was released linking Type 2 diabetes in women with the popular statin drug. Attorneys filing claims for the victims have stated the cases could well reach 10,000.

Cholesterol-lowering statin drugs are a $100 billion a year industry. Lipitor is by far the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug have exceeded $140 billion.

Lipitor benefited from the change in marketing laws in 1997 that allowed pharmaceutical companies in the U.S. to advertise their products directly to consumers. Pfizer convinced an entire generation of Americans that they needed a pill to lower their cholesterol in order to prevent heart disease, in what will go down as one of the most brilliant and unethical marketing schemes of all time.

After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which includes: liver injury, memory loss, diabetes, and muscle damage. Soon after issuing these warnings, the lawsuits started trickling in. Today, with more and more studies being published linking statin drug use to various side effects, those lawsuits have become a tidal wave, even though you are not likely to hear much about this in the mainstream media.

Study: Cholesterol-Lowering Statin Drugs Increase Bell’s Palsy Study: Cholesterol-Lowering Statin Drugs Increase Bell’s Palsy

A study just published in the international journal Drug Safety found a positive association between regular statin drug use and Bell’s palsy, a neurologic disorder.

This study confirms what Dr. Stephanie Seneff published back in 2009, showing how stain drugs used to lower cholesterol could be a main cause of Alzheimer’s and other neurological diseases in old age.

Lawsuits Against Pfizer for Lipitor Could Reach 10,000 Lawsuits Against Pfizer for Lipitor Could Reach 10,000

We reported last week here at Health Impact News that lawsuits filed against a manufacturer of cholesterol-lowering statin drugs had exceeded 1,000 claims just since April this year, primarily against Pfizer’s Lipitor.

Today, the mainstream media has finally picked up the story, as Reuter’s ran a report widely distributed over several mainstream news sites. In the Reuters’ story, Jessica Dye reports that U.S. women who say Lipitor gave them type-2 diabetes shot up from 56 to almost 1,000 court lawsuits in less than 5 months.

Dye also interviewed H. Blair Hahn of Mount Pleasant, South Carolina, the lead lawyer appointed to represent Lipitor plaintiffs in federal court. “We will ask a jury to decide what it’s worth to take five years of someone’s life,” Hahn reportedly said.

Hahn also stated that the 1,000 cases filed so far represent 4,000 women, and that the number of cases could ultimately reach 10,000 or more.

New Cholesterol Drug Approval to be Fast-tracked by FDA to Highest Bidder New Cholesterol Drug Approval to be Fast-tracked by FDA to Highest Bidder

Fresh off recent news that more than 1,000 people have filed lawsuits for damages due to cholesterol-lowering drugs since April this year, comes the remarkable story reported in the Wall Street Journal that Regeneron Pharmaceuticals, Inc. and Sanofi SA are spending $67.5 million to purchase a voucher that will allow them to get the FDA to fast-track approval of a new class of cholesterol drugs. By purchasing this voucher, they hope to beat rival drug company Amgen, Inc. in being first to market with these new cholesterol-lowering drugs.

Bloomberg Businessweek is reporting that this is a first-of-its-kind deal offered by the FDA to fast track a drug through the purchase of a voucher. However, the original voucher issued by the FDA was not even for a cholesterol lowering drug. It was originally issued to BioMarin Pharmaceutical under a 2012 law designed to reward companies for investing in drugs for rare childhood diseases. This law, which the FDA says was “intended to encourage the development of treatments for rare pediatric diseases,” also allowed those awarded such vouchers to sell them to other drug companies for the development of other drugs.

This has effectively created a type of legal “black market” where drug companies can sell these vouchers to the highest bidder, even though they were intended by the FDA to approve new drugs specifically for the “development of treatments for rare pediatric diseases.” Since this apparently does not raise any ethical questions in the mainstream media, I will raise them here.

Doctors Warning: Cholesterol Drug Risks Being Ignored Doctors Warning: Cholesterol Drug Risks Being Ignored

Top Irish surgeon warns statins raise chances of cancer and Parkinson’s in otherwise healthy people.

Sherif Sultan, of University College Hospital in Galway, warned that statin use can increase the risk of diabetes, cataracts and male impotence.

“They can also significantly increase the risk of cancer and neurodegenerative disorders such as Parkinson’s disease in the elderly, along with a myriad of infectious diseases,” he said.

Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry Thousands Sue for Damages Against Cholesterol Drugs as Big Pharma Defends Billion Dollar Industry

The $100 billion dollar cholesterol-lowering statin drug industry is under attack, as thousands of Americans are filing lawsuits against the manufacturers cholesterol-lowering drugs such as Lipitor. Research continues to confirm just how dangerous these drugs are, with yet another study published recently linking increased statin drug use to type 2 diabetes. Since the study was published by the American Diabetes Association, these known risks to cholesterol-lowering drugs can no longer be denied or defended, and the lawsuits are pouring in at a rapid pace. Most of the lawsuits at this point are from women who have suffered with diabetes as a result of taking cholesterol-lowering drugs, but lawsuits over breast cancer, Alzheimer’s, liver damage and others may soon follow now that it is generally known how dangerous these drugs are.

According to statistics supplied by various law firms, there were 464 claims filed against Lipitor as of April 15, 2014, which increased to 703 by May 15, and then to 846 by June 16. As of mid-July 2014 over 959 claims have been filed for damages due to Lipitor alone. There are also many claims currently filed against Crestor, the next nearest competitor to Lipitor, and undoubtedly other similar drugs now sold under generic labels. These lawsuits now number well over 1,000, and are increasing at a rapid pace. Yet, this news is largely blacked out of the mainstream media.

700 Lipitor and Diabetes Lawsuit Claims Filed Against Pfizer 700 Lipitor and Diabetes Lawsuit Claims Filed Against Pfizer

Before its patent expired, Lipitor was the best-selling drug of all time. Lipitor, the drug that artificially lowers cholesterol, outsold almost all other drugs combined during the height of its run, before the patent ran out allowing generics to enter the market. The FDA did not issue warnings about the dangerous side effects of cholesterol-lowering drugs until after Lipitor’s patent expired.

The information here comes from an attorney, as attorneys across the nation see the economic opportunities now to sue Pfizer for damage done to millions of peoples’ health.

Time Magazine: We Were Wrong About Saturated Fats Time Magazine: We Were Wrong About Saturated Fats

Reversing over 50 years of negative press on the “dangers” of saturated fats, Time Magazine has finally admitted that the war on saturated fats was based on bad science and was wrong. Why this sudden change of heart, and can we expect other mainstream media sources to follow suit? Will the USDA dietary guidelines now finally change?

Don’t count on it. There is much more at stake here than just butter verses margarine. At stake is a multi-billion dollar statin drug industry to lower cholesterol. The cholesterol drug war rages on.

UK Doctors Speak out on Dangers of Increase in Cholesterol-lowering Statin Drug Use UK Doctors Speak out on Dangers of Increase in Cholesterol-lowering Statin Drug Use

Millions of people over the age of 50 risk harming their health if they follow new NHS guidance telling them to take statins, leading doctors have warned the Health Secretary.

Proposals to advise 12 million people to take the drugs could have “worrying” consequences because the plans were borne out of an “overdependence” on studies funded by the pharmaceutical industry, they say.

The group cites research, independent of the drug industry, showing that statins have been associated with a 48 per cent increase in the risk of diabetes in middle-aged women. Other potential side effects could include depression, fatigue and erectile dysfunction, they warn.

American Heart Association’s Outdated Dietary Guidelines are Hurting Americans’ Health American Heart Association’s Outdated Dietary Guidelines are Hurting Americans’ Health

The American Heart Association’s woefully outdated dietary guidelines are hurting Americans’ health.

Last December, we told you about the American Heart Association’s (AHA) new new cholesterol guidelines that would make 33 million healthy Americans dependent on statins. These are the most widely prescribed class of drugs in the world—drugs so dangerous that the FDA mandates their side effects be disclosed in labeling.

The problem with AHA’s “logic?” Not only has this bad/good cholesterol dichotomy been solidly debunked by study after study—it was never proven in the first place. According to the Wall Street Journal, the notion that saturated fats and LDL clog our arteries came from a “derailment” of nutrition policy “by a mixture of personal ambition, bad science, politics, and bias.”

This article takes a look at some of the other AHA dietary guidelines, accompanied by reasons why they actually are bad for your heart.



Get the news right in your inbox!